WebMar 8, 2024 · Osteal Therapeutics completed an oversubscribed $30 million Series B equity financing. Proceeds will enable Osteal to continue development of its integrated technologies, advance the clinical development of its lead candidate VT-X7 for treatment of periprosthetic joint infection (PJI) and fund new research. WebDec 10, 2024 · Osteal Therapeutics, Inc. ClinicalTrials.gov Identifier: NCT04662632 Other Study ID Numbers: JPS-0301 : First Posted: December 10, 2024 Key Record Dates: Last …
Osteal Therapeutics - Crunchbase Company Profile & Funding
WebDavid F. Cash founded Stanmore Development LLC. Mr. Cash occupies the position of Chief Executive Officer of ZKR Ortho and Managing Partner at Stanmore Medical Investments LLC. He is also on the board... WebDec 29, 2024 · Osteal Therapeutics is a privately held, clinical-stage biopharmaceutical company developing novel musculoskeletal therapeutics to treat ... Osteal Therapeutics, … should air filter arrow face up or down
Osteal Therapeutics Inc - Company Profile and News
WebMar 8, 2024 · Series B financing led by HM Capital and joined by returning investors JJDC and Medvest Capital Proceeds will support clinical development of lead candidate, VT-X7 for periprosthetic joint infection. DALLAS, March 08, 2024 (GLOBE NEWSWIRE) -- Osteal Therapeutics, Inc. (“Osteal”), a clinical-stage biopharmaceutical company developing a … WebMar 23, 2024 · Osteal Therapeutics is headquartered in Delaware, the US. GlobalData's Medical Devices company profile report, “Osteal Therapeutics Inc Pipeline Insight and Competitive Landscape, 2024" provides information about the company overview and analysis on their pipeline products. This company profile report provides key information … WebMar 13, 2024 · Vice President, Market Access at Osteal Therapeutics . Kathy has served as Osteal Therapeutics since August 2024. She brings over 20 years of commercial … should airports be privatized